---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-006584"
form_type: "8-K"
ticker: "VVOS"
cik: "0001716166"
company_name: "Vivos Therapeutics, Inc."
filed_at: "2025-02-14T23:59:59+00:00"
generated_at: "2026-05-26T21:27:29.440711+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Vivos Therapeutics enters $3.3M ATM equity offering with H.C. Wainwright

## Summary
- Filed ATM offering agreement to sell up to $3,328,881 of common stock through H.C. Wainwright.
- Wainwright will receive a 3% cash commission on gross sales proceeds as agent.
- Offering terminates upon sale of all shares or earlier termination by either party.
- Amended employment agreements for CEO Huntsman and CFO Amman effective Jan 1, 2025 (previously reported).

## SEC filing metadata
- accession: 0001493152-25-006584
- form_type: 8-K
- ticker: VVOS
- cik: 0001716166
- company_name: Vivos Therapeutics, Inc.
- filed_at: 2025-02-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716166/000149315225006584/0001493152-25-006584-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716166/000149315225006584/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-006584
- JSON: https://secwatch.observer/filing/0001493152-25-006584.json
- Plain text: https://secwatch.observer/filing/0001493152-25-006584.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.